View Information Collection (IC) List View Supporting Statement and Other Documents
Blank fields in records indicate information that was not collected or not collected electronically prior to July 2006.


View ICR - OIRA Conclusion



0910-0389 200204-0910-001
Historical Active 199904-0910-002
HHS/FDA
Guidance for Industry: Fast Track Drug Development Programs - Designation, Development & Application Review
Extension without change of a currently approved collection   No
Regular
Approved with change 06/12/2002
Retrieve Notice of Action (NOA) 04/12/2002
Approved consistent with clarifications in FDA memos (3) of 6-12- 02. When FDA publishes the notice of approval for this collection, it shall include the public burden statement in the notice. For future guidances that impose information collections and when changes are made to existing guidances, FDA shall include the OMB number and burden statement in the guidance. FDA does not need to include the expiration date in these cases.
  Inventory as of this Action Requested Previously Approved
08/31/2005 08/31/2005 06/30/2002
86 0 114
6,480 0 9,000
0 0 0